1 Min Read
Jan 12 (Reuters) - Revive Therapeutics Ltd
* Revive Therapeutics engages Massachusetts General Hospital for cystinuria phase 2 study Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.